D'Orazio & Associates, Inc. Eli Lilly & CO Transaction History

D'Orazio & Associates, Inc.

$619 Million
Q1 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 1,936 shares of LLY stock, worth $1.77 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,936

Previous 1,888 2.54%

Holding current value

$1.77 Million

Previous $1.1 Million 36.91%

% of portfolio

0.24%

Previous 0.2%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $28,425 - $38,029	48 Added 2.54%	1,936 $1.51 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $28,885 - $34,052	55 Added 3.0%	1,888 $1.1 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $99,981 - $137,839	230 Added 14.35%	1,833 $984,000
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $211,846 - $283,263	-604 Reduced 27.37%	1,603 $751,000
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $204,083 - $239,686	-657 Reduced 22.94%	2,207 $757,000

Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $113,185 - $131,883	352 Added 14.01%	2,864 $0
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $134,008 - $152,717	452 Added 21.94%	2,512 $812,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $186,191 - $218,616	668 Added 47.99%	2,060 $668,000
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $110,773 - $137,663	472 Added 51.3%	1,392 $399,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $37,774 - $46,878	168 Added 22.34%	920 $254,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $23,932 - $29,452	108 Added 16.77%	752 $174,000
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $11,555 - $14,946	-64 Reduced 9.04%	644 $148,000
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $164 - $212	1 Added 0.14%	708 $132,000
Q4 2020 Feb 05, 2021	BUY	$130.46 - $172.63 $130 - $172	1 Added 0.14%	707 $119,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $146 - $169	1 Added 0.14%	706 $105,000
Q2 2020 Jul 22, 2020	BUY	$136.42 - $164.18 $136 - $164	1 Added 0.14%	705 $116,000
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $119 - $147	1 Added 0.14%	704 $98,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $2,031 - $2,516	-19 Reduced 2.63%	703 $92,000
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.14%	722 $81,000
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $997 - $1,163	9 Added 1.26%	721 $80,000
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $1,447 - $1,703	13 Added 1.86%	712 $92,000
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $105 - $118	1 Added 0.14%	699 $81,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.14%	698 $75,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $75 - $86	1 Added 0.14%	697 $59,000
Q1 2018 May 04, 2018	BUY	$74.21 - $87.6 $148 - $175	2 Added 0.29%	696 $54,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $81 - $87	1 Added 0.14%	694 $59,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $53,409 - $59,279	693	693 $59,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Eli Lilly & CO Transaction History